Thomas M. Gress

27.2k total citations · 4 hit papers
285 papers, 15.8k citations indexed

About

Thomas M. Gress is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Thomas M. Gress has authored 285 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Oncology, 91 papers in Molecular Biology and 75 papers in Epidemiology. Recurrent topics in Thomas M. Gress's work include Pancreatic and Hepatic Oncology Research (113 papers), Neuroendocrine Tumor Research Advances (65 papers) and Pancreatitis Pathology and Treatment (40 papers). Thomas M. Gress is often cited by papers focused on Pancreatic and Hepatic Oncology Research (113 papers), Neuroendocrine Tumor Research Advances (65 papers) and Pancreatitis Pathology and Treatment (40 papers). Thomas M. Gress collaborates with scholars based in Germany, United States and United Kingdom. Thomas M. Gress's co-authors include Patrick Michl, Malte Buchholz, Albrecht Neeße, Guido Adler, Anja Rinke, G. Adler, David A. Tuveson, Rudolf Arnold, André Menke and Markus M. Lerch and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Thomas M. Gress

275 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

2009 1.8k citations Anja Rinke, Hans‐Helge Müller et al. Journal of Clinical Oncology profile →
Stromal biology and therapy in pancreatic cancer

2010 604 citations Albrecht Neeße, Patrick Michl et al. Gut profile →
Stromal biology and therapy in pancreatic cancer: a changing paradigm

2015 419 citations Albrecht Neeße, Hana Algül et al. Gut profile →
Chronic pancreatitis

2017 300 citations Markus M. Lerch, Thomas M. Gress et al. profile →

Peers

Countries citing papers authored by Thomas M. Gress

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Gress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Gress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Gress more than expected).

Fields of papers citing papers by Thomas M. Gress

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Gress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Gress. The network helps show where Thomas M. Gress may publish in the future.

Co-authorship network of co-authors of Thomas M. Gress

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Gress. A scholar is included among the top collaborators of Thomas M. Gress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Gress. Thomas M. Gress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy 2024 ·Neoplasia ·(unknown), (unknown), (unknown), Brigitte Lankat–Buttgereit, Thomas M. Gress, Malte Buchholz, Eike Gallmeier	3
2	Combined analysis of a serum mRNA/miRNA marker signature and CA 19‐9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adenocarcinoma: A prospective multicenter cohort study 2024 ·United European Gastroenterology Journal ·Malte Buchholz, Ludwig Lausser, (unknown), Julie Earl, Rita T. Lawlor, Aldo Scarpa, Alfonso Sanjuánbenito, Alfredo Carrato, Núria Malats, Christine Tjaden, Nathalia A. Giese, Markus W. Büchler, Thilo Hackert, Hans A. Kestler, Thomas M. Gress	0
3	Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage–T Cell Interaction for Intratumoral T Cell Motility 2024 ·Cancers ·(unknown), Vincent Zimmer, (unknown), Veronika Lutz, Magdalena Huber, Malte Buchholz, Thomas M. Gress, Katrin Roth, Christian Bauer	0
4	DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer 2024 ·Gut ·Anna Brichkina, (unknown), (unknown), Rajeev Singh, Veronika Lutz, Felix S.R. Picard, Andrea Nist, Thorsten Stiewe, Johannes Graumann, Michael Daude, Wibke E. Diederich, Florian Finkernagel, Ho‐Ryun Chung, Detlef K. Bartsch, Katrin Roth, Corinna U. Keber, Carsten Denkert, Magdalena Huber, Thomas M. Gress, Matthias Lauth	8
5	Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors 2023 ·Journal of Neuroendocrinology ·(unknown), Thomas M. Gress, Anja Rinke, Andreas H. Mahnken	1
6	IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model 2023 ·Cancer Immunology Research ·Veronika Lutz, (unknown), Felix S.R. Picard, Hartmann Raifer, (unknown), Matthias Klein, Tobias Bopp, Rajkumar Savai, Peter Duewell, Corinna U. Keber, Andreas Weigert, Ho‐Ryun Chung, Malte Buchholz, André Menke, Thomas M. Gress, Magdalena Huber, Christian Bauer	39
7	1185MO Activity and safety of avelumab alone or in combination with cabozantinib in patients with advanced high grade neuroendocrine neoplasias (NEN G3) progressing after chemotherapy. The phase II, open-label, multicenter AVENEC and CABOAVENEC trials 2023 ·Annals of Oncology ·Matthias M. Weber, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, (unknown), Patrick Michl, Thomas M. Gress, Daniel‐Christoph Wagner, Wilfried Roth, (unknown), Christian Ruckes, Peter R. Galle, Christian Fottner	4
8	High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent 2022 ·Journal of Neuroendocrinology ·Elettra Merola, Aurel Perren, Anja Rinke, Alessandro Zerbi, Mairéad G. McNamara, Ruža Arsenić, Nicola Fazio, Wouter W. de Herder, Juan W. Valle, Thomas M. Gress, Bertram Wiedenmann, Andreas Pascher, Marianne Pavel	9
9	The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease 2022 ·Cancers ·Sebastian Krug, (unknown), (unknown), (unknown), (unknown), (unknown), Jens Walldorf, Philipp A. Reuken, Tania Amin, Alexander Siebenhüner, Jonas Rosendahl, Thomas M. Gress, Patrick Michl, Jörg Schrader, Anja Rinke	2
10	Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine? 2021 ·Gut ·Anja Rinke, Christoph J. Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita T. Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sørbye, Marianne Pavel, Matthias M. Weber, Irvin M. Modlin, Thomas M. Gress	24
11	Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons! 2019 ·Gut ·Asbjørn Mohr Drewes, Marinus A. Kempeneers, Dana K. Andersen, Lars Arendt‐Nielsen, Marc G. Besselink, Marja A. Boermeester, Stefan A.W. Bouwense, Marco J. Bruno, Martin L. Freeman, Thomas M. Gress, Jeanin E. van Hooft, Bart Morlion, Søren Schou Olesen, Hjalmar van Santvoort, Vikesh K. Singh, John A. Windsor	44
12	GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression 2016 ·Molecular Cancer Therapeutics ·Sandra Baumgart, (unknown), Jin‐San Zhang, Daniel D. Billadeau, Irina N. Gaisina, Alan P. Kozikowski, Shiv K. Singh, Daniel Fink, Philipp Ströbel, Caroline Klindt, Lizhi Zhang, William R. Bamlet, Alexander Köenig, Elisabeth Heßmann, Thomas M. Gress, Volker Ellenrieder, Albrecht Neeße	37
13	PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways 2015 ·Cancer Research ·Brajesh P. Kaistha, Holger Lorenz, Harald Schmidt, Bence Sipos, Michael Pawlak, Berthold Gierke, (unknown), Brigitte Lankat–Buttgereit, (unknown), (unknown), (unknown), (unknown), Johann M. Kraus, Kristopher K. Frese, (unknown), Nathalia A. Giese, Hans A. Kestler, Thomas M. Gress, Malte Buchholz	51
14	Stromal biology and therapy in pancreatic cancer: a changing paradigm breakdown → 2015 ·Gut ·Albrecht Neeße, Hana Algül, David A. Tuveson, Thomas M. Gress	419
15	Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation 2014 ·Gut ·Barbara Behm, Pietro Di Fazio, Patrick Michl, Daniel Neureiter, Ralf Kemmerling, Eckhart G. Hahn, Deike Strobel, Thomas M. Gress, Detlef Schuppan, (unknown)	55
16	Abdominal pain following percutaneous mitral valve repair (MitraClip) 2014 ·Gut ·Albrecht Neeße, Wilhelm Nimphius, Michael Schoppet, Thomas M. Gress	4
17	Correction 2010 ·Gut ·Peter Langer, Thomas M. Gress, Detlef K. Bartsch, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
18	Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group breakdown → 2009 ·Journal of Clinical Oncology ·Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger, Klaus‐Jochen Klose, Peter Barth, M. Wied, Christina Mayer, Behnaz Aminossadati, Ulrich‐Frank Pape, Michael Bläker, Jan Harder, Christian Arnold, Thomas M. Gress, Rudolf Arnold	1773
19	Functional interactions between carcinoma cells and stellate cells accelerate pancreas cancer progression 2003 ·Pancreas ·(unknown), (unknown), S. Kevin Zhou, Francisco J. Díaz, Malte Buchholz, Thomas M. Gress, Marco Siech, Wilhelm Schneiderhan, G. Adler	1
20	Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis. 1995 ·Gut ·H Weidenbach, Markus M. Lerch, Thomas M. Gress, (unknown), (unknown), G. Adler	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact